TMEM106B, a risk factor for FTLD and aging, has an intrinsically disordered cytoplasmic domain
Abstract
TMEM106B was initially identified as a risk factor for FTLD, but recent studies highlighted its general role in neurodegenerative diseases. Very recently TMEM106B has also been characterized to regulate aging phenotypes. TMEM106B is a 274-residue lysosomal protein whose cytoplasmic domain functions in the endosomal/autophagy pathway by dynamically and transiently interacting with diverse categories of proteins but the underlying structural basis remains completely unknown. Here we conducted bioinformatics analysis and biophysical characterization by CD and NMR spectroscopy, and obtained results reveal that the TMEM106B cytoplasmic domain is intrinsically disordered with no well-defined three-dimensional structure. Nevertheless, detailed analysis of various multi-dimensional NMR spectra allowed defining residue-specific conformations and dynamics. Overall, the TMEM106B cytoplasmic domain is lacking of any tight tertiary packing and relatively flexible. However, several segments are populated with dynamic/nascent secondary structures and have relatively restricted backbone motions. In particular, the fragment Ser12-Met36 is highly populated with - helix conformation. Our study thus decodes that being intrinsically disordered allows the TMEM106B cytoplasmic domain to dynamically and transiently interact with a variety of distinct partners.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TMEM106B C-terminal fragments drive nucleocytoplasmic transport failure and TDP-43 mislocalization in the aging human brain
Kedamawit Tilahun, Janani Parameswaran, … Jie Jiang·bioRxiv·Apr 27, 2026
- Age-dependent formation of TMEM106B amyloid filaments in human brain
Manuel Schweighauser, Diana Arseni, … Sjors H. W. Scheres·NaturePeer-reviewed·Mar 28, 2022
- TMEM106B C-terminal fragments aggregate and drive neurodegenerative proteinopathy.
Ruben Riordan, Aleen D. Saxton, … Brian C. Kraemer·bioRxiv·Jun 11, 2024
- Neurodegeneration risk variants promote lysosomal TMEM106B fibrilaccumulation
John Michael Replogle, Jordan D. Marks, … Michael Emmerson Ward·bioRxiv·Mar 28, 2026
- Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism
Hideyuki Takahashi, Azucena Pérez‐Cañamás, … Stephen M. Strittmatter·Communications BiologyPeer-reviewed·Sep 5, 2024
- TMEM106B C-Terminal fragment aggregation exacerbates α-synuclein and TDP-43 proteinopathy phenotypes.
Ruben Riordan, Aileen Saxton, … Brian C. Kraemer·bioRxiv·Oct 30, 2026